NINDS invites applications for phase III investigator-initiated multi-site clinical trials.
Phase III clinical trials are the most complex and challenging trials to design and implement. For completion within the funding period and budget, awarded clinical trials need extensive planning and proactive oversight. In addition to lengthy study start-up, slow participant enrollment can cause trial delays and result in the need of additional funding in order to complete the planned trial. This announcement provides a mechanism suitable for the submission and successful implementation of a large, complex phase III clinical trial, incorporating several stages to allow the investigators and NINDS to assess study progress and feasibility.
Potential applicants should contact Dr. Scott Janis, clinical research project manager, Office of Clinical Research, NINDS, at 301-496-9135 or email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-11-173.html.